Evidence map›Paper›PMID 24169519›Full record

ArticleEuropean journal of human genetics : EJHG2014

20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition.

Amélie Piton, Hélène Poquet, Claire Redin, Alice Masurel, Julia Lauer, Jean Muller, Julien Thevenon, Yvan Herenger, Sophie Chancenotte, Marlène Bonnet and 11 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. REM sleep behavior disorder in Brunner syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.Annals of clinical and translational neurology · 2019
    Article
  14. Article
  15. Review
  16. Exome Pool-Seq in neurodevelopmental disorders.European journal of human genetics : EJHG · 2017
    Article
  17. Serotonin neuron abnormalities in the BTBR mouse model of autism.Autism research : official journal of the International Society for Autism Research · 2017
    Article
  18. Polymorphisms in the canine monoamine oxidase a (Canine genetics and epidemiology · 2017
    Article
  19. Review
  20. MAOA Influences the Trajectory of Attentional Development.Frontiers in human neuroscience · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Amélie Piton1] IGBMC, CNRS UMR 7104/INSERM U964/University of Strasbourg, Illkirch Cedex, France [2] Chaire de Génétique Humaine, Collège de France, Paris, France.
Hélène Poquet1] Centre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France [2] Service de Pédopsychiatrie, Hôpital d'Enfants, Dijon, France.
Claire Redin1] IGBMC, CNRS UMR 7104/INSERM U964/University of Strasbourg, Illkirch Cedex, France [2] Chaire de Génétique Humaine, Collège de France, Paris, France.
Alice MasurelCentre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France.
Julia LauerLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Jean Muller1] IGBMC, CNRS UMR 7104/INSERM U964/University of Strasbourg, Illkirch Cedex, France [2] Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Julien Thevenon1] Centre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France [2] EA 4271 GAD, Faculté de Médecine, Université de Bourgogne, Dijon, France.ORCID 0000000192713961
Yvan HerengerLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Sophie Chancenotte1] Centre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France [2] Centre Référent des Troubles du Langage et des Apprentissages, Hôpital d'Enfants, Dijon, France.
Marlène BonnetCentre Référent des Troubles du Langage et des Apprentissages, Hôpital d'Enfants, Dijon, France.
Jean-Michel PinoitService de Pédopsychiatrie, Hôpital d'Enfants, Dijon, France.
Frédéric HuetCentre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France.
Christel Thauvin-Robinet1] Centre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France [2] EA 4271 GAD, Faculté de Médecine, Université de Bourgogne, Dijon, France.
Anne-Sophie JaegerLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Stéphanie Le GrasIGBMC, Microarray and Sequencing Platform, Illkirch, France.
Bernard JostIGBMC, Microarray and Sequencing Platform, Illkirch, France.
Bénédicte GérardLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Katell Peoc'hService de Biochimie et de Biologie Moléculaire, Groupe Hospitalier Universitaire Saint-Louis Lariboisière Fernand-Widal, AP-HP, Paris, France.
Jean-Marie LaunayService de Biochimie et de Biologie Moléculaire, Groupe Hospitalier Universitaire Saint-Louis Lariboisière Fernand-Widal, AP-HP, Paris, France.
Laurence Faivre1] Centre de génétique et Centre de Référence Anomalies du développement et Syndromes malformatifs, Hôpital d'Enfants, Dijon, France [2] EA 4271 GAD, Faculté de Médecine, Université de Bourgogne, Dijon, France.
Jean-Louis Mandel1] IGBMC, CNRS UMR 7104/INSERM U964/University of Strasbourg, Illkirch Cedex, France [2] Chaire de Génétique Humaine, Collège de France, Paris, France [3] Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, France.
Hôpital d'Enfants · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires de Strasbourg · FRUniversité de Bourgogne · FRAssistance Publique – Hôpitaux de Paris · FRInstitut de génétique et de biologie moléculaire et cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intellectual disability (ID) is characterized by an extraordinary genetic heterogeneity, with >250 genes that have been implicated in monogenic forms of ID. Because this complexity precluded systematic testing for mutations and because clinical features are often non-specific, for some of these genes only few cases or families have been unambiguously documented. It is the case of the X-linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in a single family by mild non-dysmorphic ID and impulsive, violent and aggressive behaviors. We have performed targeted high-throughput sequencing of 220 genes, including MAOA, in patients with undiagnosed ID. We identified a c.797_798delinsTT (p.C266F) missense mutation in MAOA in a boy with autism spectrum disorder, attention deficit and autoaggressive behavior. Two maternal uncles carry the mutation and have severe ID, with a history of maltreatment in early childhood. This novel missense mutation decreases MAOA enzymatic activity, leading to abnormal levels of urinary monoamines. The identification of this new point mutation confirms, for the first time since 1993, the monogenic implication of the MAOA gene in ID of various degrees, autism and behavioral disturbances. The variable expressivity of the mutation observed in male patients of this family may involve gene-environment interactions, and the identification of a perturbation in monoamine metabolism should be taken into account when prescribing psychoactive drugs in such patients.

Indexed as

Mutation, MissenseAmino Acid SequenceAttention Deficit and Disruptive Behavior DisordersBase SequenceChild Development Disorders, PervasiveFamily HealthFemaleGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansIntellectual DisabilityMaleModels, MolecularMonoamine OxidasePedigreeProtein Structure, TertiaryMonoamine Oxidase

Identifiers

PMID24169519
PMCPMC4023218
OpenAlexW2037246149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.